1. Introduction to Inflammation and Cancer 2. Chronic Inflammation and Cancer: Epidemiological Evidence 3. Role of Inflammatory Cells in Cancer Development 4. The Tumor Microenvironment and Inflammation 5. Cytokines and Chemokines in Tumorigenesis and Their Pro-tumorigenic and Anti-tumorigenic Roles in Cancer Development 6. The Role of Oxidative Stress in Inflammation-Mediated Cancer Progression Inflammation and Metastasis 7. Genetic and Epigenetic Changes Driven by Inflammation 8.
Epigenetic Signaling: Regulation of Inflammation in Cancer 9. Inflammation and Tumor Progression: Signaling Pathways 10. Biomarkers and Signaling Pathways of Inflammation-Mediated Cancer Development: Promising Targets to Limit 11. Metastatic Potential and Stemness 12. Anti-inflammatory Agents in Cancer Prevention and Therapy 13. Tumor-Infiltrating Inflammatory Cells as Possible Therapeutic Targets 14. The Inflammatory Chemokines and in Malignancy: Leukocyte Migration and Beyond 15. Inflammation and Beyond: Complex Roles for TGF-β in the Tumor Microenvironment 16.
Microenvironmental Mediators as Therapeutic Targets in Malignancy 17. Role of Macrophages in Regulating Tumor Angiogenesis: Implications for Cancer Therapy 18.Immune Forces Impacting DNA-Based Cancer Immunotherapeutic Strategy 19. Immunotherapy and Inflammation 20.Case Studies: Inflammation-targeted Cancer Therapies 21. Microbiota, Inflammation and Colorectal Cancer 22. Genomics and Microbiome and Their Immunotherapy Implications in Cancer 23. Modulation of Tumor Immunogenicity 24.
Biomarkers Associated with Immunotherapeutic Response in Cancer 25. Endoscopy and AI in the Diagnosis and Early Detection of Dysplastic Lesions 26. Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction 27.Combinational Immunotherapy Against Cancer 28. Policy Recommendations Regarding Immunotherapy and Other Cancer Therapy.